Anti-PD-1 for HBV? https://www.prnewswire.com/news-releases/ascletis-and-alphamab-announce-strategic-collaboration-and-licensing-agreement-for-anti-pd-l1-to-treat-hepatitis-b-and-other-viral-diseases-300777345.html